- Supported exchanges /
- F /
- 5HJ.F
ENVVENO MEDICAL DL-00001 (5HJ F) stock market data APIs
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of venous Chronic Venous Insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg; and enVVe, a non-surgical, transcatheter based replacement venous valve for the treatment of CVI. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
ENVVENO MEDICAL DL-00001 Financial Data Overview
| 3.1 | |
| 3.1 | |
| - | |
| 3.1 | |
| 3.1 | |
| 2.7-6.05 | |
| 54 361 K | |
| 17 536 K | |
| 0 | |
| 1.212 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
ENVVENO MEDICAL DL-00001 Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -22 367 000
- Earnings Per Share -1.28
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get ENVVENO MEDICAL DL-00001 Earnings via APIs
- Latest Release 2024-11-01
- EPS/Forecast NaN
Get ENVVENO MEDICAL DL-00001 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
